| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |